Support mechanisms for non-commercial clinical trials | Level | |||||||
National | EU Level (Multinational) | Global | ||||||
Dedicated webpage | ||||||||
Training courses | ||||||||
Scientific advice | ||||||||
Helpdesk, regulatory, CTIS and ethics support | ||||||||
Other services by National Competent Authority | Fee reduction / waiver Fees for academic research without support from industry benefit from a fee exemption of 70% of full fee. Decisions on fee exemptions are at the discretion of the Medicines Authority. For more information: LEĠIŻLAZZJONI MALTA (legislation.mt) | X | ||||||
Services by ethics committee | ||||||||
Public GCP support | ||||||||
Public research office | ||||||||
National funding and other financial support | National funding support to support companies planning to set up in Malta and run clinical trials may be possible through Malta Enterprise. For more information: Incentive Guidelines (maltaenterprise.com). | X | ||||||
Funding coordination and navigation of research infrastructure | ||||||||
Support identifying research networks | ||||||||
Other support mechanisms | Help with reporting of Suspected Unexpected Serious Adverse Reaction (SUSAR) Upon request, the Malta Medicines Authority assists non-commercial sponsors with electronic report submission to the EudraVigilance clinical trial module (EVCTM). Requests should be submitted to info [dot] medicinesauthoritygov [dot] mt (info[dot]medicinesauthority[at]gov[dot]mt) at the time of submission of the clinical trial application to facilitate timely completion of arrangements. For more information: Malta Medicines Authority: Guidance Notes for Pharmaceutical Companies on Pharmacovigilance Obligations for Medicinal Products for Human Use The Malta Medicines Authority also respons to queries from non-commercial sponsors and may arrange meetings when asked to explain the requirements for clinical trials and regulatory pathways. | X |